Application of Metal-Based Complexes in Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2409
Special Issue Editors
Interests: metallodrugs; cancer; activity descriptors; tropical neglected diseases
Special Issue Information
Dear Colleagues,
We pleased to invite you to a Special Issue of Pharmaceutics (MDPI) entitled “Application of Metal-Based Complexes in Cancer Treatment”. The aim of this Special Issue is to compile the most recent innovative approaches on metallodrugs that include the design of new molecules with particular properties that may improve cancer treatment. The manuscripts can present studies of new targets, mechanisms of action, molecular and cellular studies, omics advances and differential gene expression, among other mechanisms. High-quality original research articles and reviews are welcome. Any approach to improve cancer treatment with a special type of formulation in order to preserve the activity of metallodrugs for cancer treatment is of interest. Research areas of this SI may include (but are not limited to) the following:
- Adult tumors;
- Child tumors;
- Essential metals;
- Non-essential metals.
We look forward to receiving your contributions.
Prof. Dr. Lena Ruíz-Azuara
Prof. Dr. Carmen Mejía
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metallodrugs
- mechanism of action
- targets
- pharmaceutical formulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
